Patent · US Revoked

Immunoglobulin chimeric monomer-dimer hybrids

US10513551B2 · kind B2 · utility

0Cited by
81References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 21, 2017
Grant dateDec 24, 2019
Priority date
Expiry dateMar 21, 2037

Classification

  • Technology area (CPC —)General

Abstract

The invention relates to a chimeric monomer-dimer hybrid protein wherein the protein comprises a first and a second polypeptide chain, the first polypeptide chain comprising at least a portion of an immunoglobulin constant region and a biologically active molecule, and the second polypeptide chain comprising at least a portion of an immunoglobulin constant region without the biologically active molecule of the first chain. The invention also relates to methods of using and methods of making the chimeric monomer-dimer hybrid protein of the invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.